InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,751.07
(
0.90%
)
US TECH 100
19,476.00
(
1.10%
)
Dow Jones
42,352.75
(
0.81%
)
Brent Oil
77.97
(
0.00%
)
Bitcoin
62,710.17
(
1.02%
)
Post# of 80490
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

adreamer

Send PM Follow Ignore
Followers 2
Posts 1530
Boards Moderated 0
Alias Born 12/18/2010

adreamer

Re: lax20m post# 25456

Monday, 01/14/2013 4:48:10 PM

Monday, January 14, 2013 4:48:10 PM

Post# of 80490
Given that the report will actually represent the drugs first 3 months on the market, I think analysts will be most interested in the rate of adoption and pay close attention to how upbeat and substantive the future guidance is from Harvey. I think if they come in there and say there are 500 patients currently on Iclusig and the rate of adoption is accelerating each week... then regardless of the actual top line revenue the market could have reason to get excited.....But remember from whence this comes....DREAMER
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up